Aeta SA (0NTT)

Jay,

Yes, please feel free to post on X. To clarify, I do not say that vaccines are all misplaced, of course, but rather that they have a proper place in disease treatment when properly developed. AND to place too much reliance on just that treatment modality within the evolving lan

They can’t sell and move on.. no bid .. pumping it into oblivion with 30 billion AS 22 billion OS
$GTCH no cash no bid way to go

Blarcamesine had a proper Phase 2b/3 trial with statistically significant results.

GOD bless,

Lol, where you from?. The only record is the pump bash matrix. Take a pill.
https://investorshub.advfn.com/boards/msgsearch.aspx?searchstr=wok
$WOK
https://www.youtube.com/watch?v=7YO0clA_U-k

BMY’s 10-K:
Regarding generic Eliquis launch:
“ Under the terms of previously executed settlement agreements, the generic companies with whom BMS settled are permitted to launch in 2028, subject to additional challenges. ”

Analyzing the political implosion against an economic calamity I MUST give strong credence to the possibility we are in a countdown for a crash here. I know, my track record and willingness to see gremlins is strong. But the menel state of the investor, AKA top 5%, and the pavlova response every ti

OTC scam along with $TWOH, one is no bid, and the other one is garbage that has been at .002 for months now without moving despite the pump tactics!😆😆

Some detailed information on the carbonate question

THE HONEST BRIDGE TO ZION

There is a real, defensible connection here, and it is worth stating without inflating it:

- The transect in Figure 3 literally runs ONSHORE into southern Israel. The framework

Methinks, I think someone should tell Trump a few good jokes!!! Laughter is the best medicine!!! Well, and of course if he got a dog that would help him with his soul!!! Have you seen his eyes lately?? He doesn’t look happy very often!!!

I and many shareholders congratulate VIVO for its achievement so far of submitting the IDE application to the FDA. Best of luck to VIVO and all of us shareholders.

The only thing JPM is paying through a 3rd party is for the Euro notes/bonds.. these were always guaranteed….the rest….after 17+ years….looks very weak…this unfortunately….but keep posting your numbers….they can only be right if it happens…wait for Cactus to tell you and others dd is wrong except fo

let's do it!

Yes, but my suggestion would be to use the mid point between 35,000 and 45,000 which would be 40,000. If they dont at least come close to my numbers in Q2 I will consider moving some money elsewhere. As of right now I am still adding a little at a time.

40,000 × 40% = 16,000 in 2026-

GL...

I ignored you then gave you a second chance.
You screwed the pooch twice.
Bye Bye

>> Space-X

I saw the MHRA confirmation email that SemperFi shared. June will be over before we know it, and other than watching the share count continue to increase through dilution, we may not hear much of anything from the company. That's why even small pieces of information or reassurance from someone who h

Yep…moving forward this is very good…..this has no impact for old wamu holders….walrat should have stopped the bankruptcy case when colorful claims were realized….maybe….maybe would have a leg to stand on filing claims….aside from signing releases….still moving forward RKT will do just fine…

Zadie, I saw the MHRA confirmation email that SemperFi shared, and I appreciate that information. However, I'd still like to hear from GZ as an additional confirmation that everything remains on track. I'm also simply asking that anyone who receives a response from him share it with the board. I don

Great insight, thanks for sharing. 

Edit, Oxy patent case filed 11/9*/23.

Thanks Catfish, appreciate this simplified explanation!

Posting information about how someone believes the process will play out is not "tying your hopes" to the organization. It was posted in response to someone else's view of a huge RS incoming. I can't believe your brain computed that. That implies that the only reason the stock would move is bc of wh